معرفی
Bram van Leer is an active researcher at the University Medical Center Groningen, Department of Nuclear Medicine and Molecular Imaging, University of Groningen. His work primarily focuses on applying PET-CT imaging techniques to critical care medicine, with particular expertise in infectious disease diagnosis and monitoring in intensive care settings.
His research interests center on nuclear medicine applications in critical care, specifically using various PET tracers (including 18F-FDG and 68Ga-FAPI) to diagnose infections, inflammation, and complications in critically ill patients. His work has significant implications for patients with persistent critical illness, immunocompromised conditions, and post-COVID complications.
Van Leer's publication portfolio shows a clear trend toward applying advanced molecular imaging techniques to solve clinical challenges in intensive care units. His research spans infectious disease identification, differentiation between inflammatory conditions, and monitoring recovery processes after critical illness, with particular focus on COVID-19 related complications.
He has received media attention for his work, with expert commentary featured in multiple news outlets discussing how PET/CT imaging reveals infections in ICU patients and how COVID-19 manifests in critically ill patients. His research has been shared across various social media platforms including X, Facebook, and Bluesky, with significant academic engagement through Mendeley readership.
Van Leer actively collaborates with leading researchers in nuclear medicine and critical care, including Slart, Pillay, and Glaudemans, contributing to both clinical research and technical advancements in PET/CT imaging applications for cardiovascular and pulmonary conditions in critical care settings.
